Published in Respiratory Therapeutics Week, January 3rd, 2005
The financing was arranged primarily to support the company's 2005 marketing and media plan.
The funds also will be used to pay off the company's current senior secured creditor and to meet costs of general business operations.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Respiratory Therapeutics Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.